We have been working with Rephine for many years on multiple projects, and their expertise, professionalism, and deep understanding of regulatory requirements never fail to impress us. Their guidance throughout the DMF submission was key for our success.
About this Case Study
An international API manufacturer partnered with Rephine to navigate China’s complex Drug Master File (DMF) submission process. Rephine’s cross-border team ensured compliance with NMPA guidelines, provided accurate translations, acted as the local regulatory agent, and managed CDE deficiency responses—streamlining approval.
The result was a fully compliant DMF and accelerated market access, supported by Rephine’s dual-region expertise.
“Rephine’s deep regulatory knowledge and responsiveness were crucial to our successful approval in China.”
— Panreac Quimica
Learn how Rephine can simplify your market entry and download the full case study now.
Download the Case Study
View other our other resources and company news
Article GDP Transport Validation: A Practical Guide for Pharmaceutical Companies
Article Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide
Article MDR & IVDR Compliance: A Strategic Approach for MedTech
Medical Device MDR & IVDR Compliance as a Business Outcome
Case Study Full GMP Internal Audit Program Executed On Time
QMS From local to global: scaling your QMS for UK–EU operations
QMS Scale Your Quality System from UK to EU Without Losing Control
Article Pharmaceutical Equipment Qualification & Control System Validation
Case Study 